Navigation Links
Alkermes in Medical News

Weekly Drug Helps Type 2 Diabetics

...aceuticals Inc., the maker of Byetta, is working with Eli Lilly and Co. and alkermes Inc. to develop exenatide once weekly. More than 21 million people in th... SOURCE: Amylin Pharmaceuticals Inc., Eli Lilly and Co., alkermes Inc., news release, June 9, 2008 ...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...nhaled insulin program. A two-year safety trial and other studies are ongoing for both the inhaled insulin formulation and device. Lilly and alkermes currently expect regulatory submission to the FDA in 2009. -- Arzoxifene - A Phase III osteoporosis prevention trial that enrolled over 30...

Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study

... http://www.BYETTA.com . About Amylin, Lilly, and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide long-act...mprove the lives of patients with serious disease. alkermes currently has two commercial products: RISPERDAL(R...

Drug Approved to Curb Alcohol Dependency

...rs while acamprosate has its effect on a neurotransmitter. They both have been approved by Food and Drug Administration approval. Naltrexone, made by alkermes Inc. as an injectable form, to be taken monthly, will be marketed by Cephalon Inc. The results of the study have been published in the Journal o...

Alcoholism Drug Vivitrol Approved By FDA

...ypersensitivity to naltrexone, PLG or any other components of the diluent," alkermes and Cephalon said in a statement. Patients must be opioid free for at least...hould be monitored for the development of depression or suicidal thinking," alkermes and Cephalon said. Some 18 million Americans abuse or are dependent o...
Alkermes in Medical Technology

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

...addiction. The family of compounds was licensed to alkermes Inc., and the company identified a lead product ca...granting Massachusetts-based biotechnology company alkermes exclusive rights to a library of compounds discove...diction, pain, and other nervous system disorders. alkermes screened the library of compounds from Rensselaer ...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

...ic control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...and Annual Reports on Form 10-K. Amylin, Lilly and alkermes undertake no duty to update these forward-looking ...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...
Alkermes in Biological Technology

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

..., including three successful new drug applications for these products. He has worked with several pharmaceutical and biotechnology companies including alkermes in multiple therapeutic areas, including allergy, asthma, oncology, rheumatology, hematology, diagnostics, and drug delivery systems. "As I join...

Cephalon's New Product Launches Pace Record 2008 Sales

...1.0 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...8.2 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...ORPORATION (NASDAQ: ADLR ) ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN ) alkermes INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC....ERS CORP (NYSE: WAT ) Add ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII ) alkermes INC (NASDAQ: ALKS ) AMERISOURCEBERGEN CORP (NYSE: ABC ) APP PHARMACEUTI...

New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated

...and behavioral diagnostic instruments. Drugs/classes mentioned in this report: ReVia (naltrexone); Vivitrol (extended release injectable naltrexone; alkermes / Cephalon); Campral (acamprosate; Forest); Antabuse (disulfiram); gabapentin (generic); Topamax (topiramate; Ortho-McNeil); Prometa (flumazanil / gab...

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

...and now is approved in more than 70 countries worldwide. The treatment uses alkermes proprietary Medisorb(R) technology to deliver and maintain therapeutic medi.... and Janssen-Cilag, a subsidiary of Johnson & Johnson, outside of the U.S. alkermes also developed and manufactures VIVITROL(R), marketed in the U.S. primarily...

Pearl Therapeutics Raises $15.5 Million in Private Financing

... development and commercialization of major products in his prior scientific, engineering and management roles at GlaxoWellcome, Dura Pharmaceuticals, alkermes and Nektar. "We are very pleased to have received strong support from top-tier and sophisticated biopharmaceutical investors," said Mr. Smith. "These...
Other Tags
(Date:9/18/2014)... 18, 2014) The National Institutes of Health (NIH) ... four-year, $1.3 million grant to the Los Angeles Biomedical ... and development of a vaccine to protect patients from ... Staphylococcus aureus (MRSA). , The National Institute ... awarded the grant to LA BioMed infectious disease specialists ...
(Date:9/18/2014)... MA (PRWEB) September 18, 2014 ChopChop ... Chef Bill Yosses and Yonah Kalikow, 10-year-old Massachusetts’s winner of ... a twist on hummus, the classic Middle Eastern bean dip. ... on stage how kids can create their own healthy dips ... AM at the third annual Let’s Talk About Food ...
(Date:9/18/2014)... 18, 2014 NexCore Group has opened ... managed by Todd Varney and Justin Pawlak, will allow ... with the benefits and best practices of NexCore’s national ... of local project delivery resources. , With a ... presence across the country over the past several years ...
(Date:9/18/2014)... -- Researchers are trying to learn more about a ... death in young athletes. In people with sickle ... cause muscle breakdown that can lead to kidney damage ... football players in the United States collapsed and died ... cell trait. "More student-athletes with sickle cell trait ...
(Date:9/18/2014)... unique partnership to support private efforts to provide mental ... a model for similar efforts should federal officials decide ... reform of the VA health system, according to a ... Initiative, a joint project of philanthropic groups and major ... care, education and other services to veterans and their ...
Breaking Medicine News(10 mins):Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3Health News:NexCore Group Opens Regional Office in Orlando, Florida 2Health News:Scientists Studying Sickle Cell Trait 2Health News:Study provides insight about providing private mental health service to veterans 2Health News:Study provides insight about providing private mental health service to veterans 3
(Date:9/17/2014)... Researchers at the Catalan Institute of Oncology-Bellvitge Biomedical ... identified 5 genes differentially expressed in normal accompanying ... could be used to classify colorectal tumors, predict ... appropriate clinical decisions to prevent relapses. , ... most common in our population considering both sexes. ...
(Date:9/17/2014)... decades of decline, grasses have returned to some once-denuded ... marsh in those places seems healthy again, but a ... the marsh coastal protection remains diminished. , ... hasn,t come back," said ecologist Mark Bertness, professor of ... in the journal Biological Conservation . "The metric ...
(Date:9/17/2014)... including MRSA and MSSA could be curbed by ... the scaly surface of shark skin, according to ... Antimicrobial Resistance and Infection Control . , The ... spread of human disease bacteria through touching, sneezes ... arrangement of ridges formulated to resemble shark skin. ...
Breaking Biology News(10 mins):Five genes to predict colorectal cancer relapses 2Cape Cod saltmarsh recovery looks good, falls short 2Cape Cod saltmarsh recovery looks good, falls short 3Sharks' skin has teeth in the fight against hospital superbugs 2
Other Contents